|
This adverse event occurred outside of the u.S.However, as there is a similar marketed device in the u.S., an mdr is being filed.At the time of complaint initiation, limited information was provided.Customer stated the mem-lok resorbable collagen membrane was used on a patient on (b)(6) 2023.The patient returned on (b)(6) 2023 and the product material had resorbed.The patient was prescirbed medication - type of medication not specified.Further information was provided, where the customer clarified the patient was prescribed antibiotics (type of antibiotics not specified) before and after the procedure.There were no notable complications during the initial procedure.Revision surgery was performed in which the implants were extracted and the defect was covered again without any augmentation.No additional procedures were planned.Additional information surrounding the patient status, patient outcome, and event details were requested but not provided.No further information was provided.
|